Home Newsfeeds Magyar Bancorp, Inc. Declares Special Cash Dividend $0.08

Magyar Bancorp, Inc. Declares Special Cash Dividend $0.08

Magyar Bancorp, Inc. (NASDAQ:MGYR) announced that its Board of Directors has declared a special cash dividend of $0.08, payable December 13, 2022 to shareholders of record on November 29, 2022.

byBenzinga Newsdesk

November 15, 2022

1 minute read

Magyar Bancorp, Inc. (NASDAQ:MGYR) announced that its Board of Directors has declared a special cash dividend of $0.08, payable December 13, 2022 to shareholders of record on November 29, 2022.

Deutsche Bank Maintains Buy on KKR & Co, Lowers Price Target to $66

By Benzinga Newsdesk

July 13, 12:50 PM

Deutsche Bank analyst Brian Bedell maintains KKR & Co (NYSE:KKR) with a Buy and lowers the price target from $79 to $66.

KKR

Nanobiotix Establishes Recommended Dose For Registrational Study Of Head & Neck Combo Therapy Trial

By Vandana Singh

September 22, 7:22 AM

Nanobiotix (NASDAQ: NBTX) determined the recommended phase 2 dose (RP2D) of the NBTXR3 combo regime for inoperable locoregional recurrent or recurrent and metastatic head and neck squamous cell carcinoma that is resistant to prior immunotherapy.

BMY

Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

January 3, 2:39 PM

Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group.

ACMR

News
Tech

Grok-Investor Pierre Ferragu Plans To Put Apple’s Newly Announced Genmoji To The ‘Test’ After Putting Elon Musk’s AI-Chatbot Through The Same ‘Benchmark’

By Ananya Gairola

June 11, 1:54 AM

Apple introduced a new artificial intelligence feature called "Apple Intelligence" at WWDC 2024, enabling users to create custom emojis, which an investor in Elon Musk's AI chatbot Grok has decided to test.

AAPL

Magyar Bancorp, Inc. Declares Special Cash Dividend $0.08

Related Posts

Deutsche Bank Maintains Buy on KKR & Co, Lowers Price Target to $66

Nanobiotix Establishes Recommended Dose For Registrational Study Of Head & Neck Combo Therapy Trial

Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

Grok-Investor Pierre Ferragu Plans To Put Apple’s Newly Announced Genmoji To The ‘Test’ After Putting Elon Musk’s AI-Chatbot Through The Same ‘Benchmark’